Harpoon Therapeutics, Inc. — Form D

Harpoon Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-06. The offering totals $45.2M, of which $25.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Patrick E BaeuerleDirectorSouth San Francisco, CA
Pablo E CagnoniDirectorSouth San Francisco, CA
Mark E ChinDirectorCambridge, MA
Luke E EvninDirectorSouth San Francisco, CA
Dan E HicklinDirectorSouth San Francisco, CA
Ron E HuntDirectorSouth San Francisco, CA
William E PichtExecutive OfficerSouth San Francsico, CA
Alan ColowickDirectorBelmont, CA
Luke WalkerExecutive OfficerNashville, TN
Andrew RobbinsDirectorNew York, NY
Joseph BailesDirectorHouston, TX
Julie EastlandDirectorSouth San Francisco, CA
Julie EastlandExecutive OfficerSouth San Francisco, CA
Mark ChinDirectorCambridge, MA
Scott MyersDirectorSouth San Francisco, CA
Jonathan DrachmanDirectorSouth San Francisco, CA
Ronald HuntDirectorSouth San Francisco, CA
Lauren SilvernailDirectorSouth San Francisco, CA
Joanne P VineyDirectorSouth San Francisco, CA
Luke Nathaniel WalkerExecutive OfficerSouth San Francisco, CA
Lauren P SilvernailDirectorSouth San Francisco, CA
Natalie R SacksExecutive OfficerBerkeley, CA
Jonathan R DrachmanDirectorSouth San Francisco, CA
Julie R EastlandDirectorSouth San Francisco, CA
Patrick R BaeuerleDirectorSouth San Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2023-10-31D$100.2M$100.2M
2023-04-07D$25.0M$25.0M
2018-11-26D$70.0M$70.0M

More